Impact of Ideal Outcome on Survival After Pancreatic Surgery
Achieving an ideal outcome (io) after pancreatoduodenectomy for resectable pancreatic head cancer significantly improves overall survival and treatment continuity.
Newsletter
Every new paper in this field, in your inbox.
Achieving an ideal outcome (io) after pancreatoduodenectomy for resectable pancreatic head cancer significantly improves overall survival and treatment continuity.
After pancreatic cancer surgery with vascular resection, portomesenteric venous thrombosis (PVT) is frequently encountered, particularly late PVT, which has significant implications for patient outcomes.
Using KRAS mutations in duodenal lavage fluid after secretin stimulation offers a promising method for identifying resectable pancreatic ductal adenocarcinoma (PDAC) with high sensitivity.
Pancreatic fistulas and fluid collections frequently occur after distal pancreatectomy, significantly impacting postoperative management.
Liver transplantation (LT) is critical for selected patients with primary liver cancers, with evolving strategies improving eligibility and outcomes through personalized treatment plans.
Chronic steroid use does not impact short-term complications or mortality in patients undergoing distal pancreatectomy.
This paper introduces the "pulley maneuver" using the Stratafix suture to improve traction and exposure in minimally invasive hepatobiliary and pancreatic surgeries.
A panel of experts reached consensus on guidelines for clinical trials evaluating systemic therapies in hepatocellular carcinoma (HCC) patients undergoing surgical or locoregional treatment, emphasizing patient selection and outcome measures.
Nonoperative management of colonic fistulas in necrotizing pancreatitis can be effective for low-risk patients, reducing complications and length of stay without affecting survival.
Transarterial chemoembolization (TACE) with apatinib significantly enhances survival in patients with unresectable hepatocellular carcinoma (UHCC) compared to TACE alone.